Stay updated on Pembrolizumab in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page shows a new revision tag v3.5.5, representing a minor metadata update to the ClinicalTrials.gov record.
    Difference
    0.1%
    Check dated 2026-06-05T09:19:44.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4 on the page, indicating a maintenance or update; the study information shown remains unchanged.
    Difference
    0.1%
    Check dated 2026-05-15T02:14:50.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    - The page now shows a new revision label (v3.5.3), replacing the previous v3.5.2. This indicates a minor update to the document.
    Difference
    0.1%
    Check dated 2026-04-30T17:31:27.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Site software version updated from v3.5.0 to v3.5.2. No user-facing changes to study content or page structure are evident.
    Difference
    0.1%
    Check dated 2026-04-16T10:16:45.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a new frontend revision label: Revision: v3.5.0, and removed the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:41:54.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision label in the site footer updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:58:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.